These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 29466778

  • 1. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity.
    Zhang Y, Liu Z, Wu J, Bai B, Chen H, Xiao Z, Chen L, Zhao Y, Lum H, Wang Y, Zhang H, Liang G.
    Eur J Med Chem; 2018 Mar 25; 148():291-305. PubMed ID: 29466778
    [Abstract] [Full Text] [Related]

  • 2. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y, Shan X, Dai Y, Jiang L, Chen G, Zhang Y, Wang Z, Dong L, Wu J, Guo G, Liang G.
    J Pharmacol Exp Ther; 2015 Jun 25; 353(3):539-50. PubMed ID: 25862641
    [Abstract] [Full Text] [Related]

  • 3. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury.
    Zhang Y, Wu J, Ying S, Chen G, Wu B, Xu T, Liu Z, Liu X, Huang L, Shan X, Dai Y, Liang G.
    Sci Rep; 2016 Apr 27; 6():25130. PubMed ID: 27118147
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.
    Chen G, Xiao B, Chen L, Bai B, Zhang Y, Xu Z, Fu L, Liu Z, Li X, Zhao Y, Liang G.
    Eur J Med Chem; 2017 Oct 20; 139():726-740. PubMed ID: 28858767
    [Abstract] [Full Text] [Related]

  • 6. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
    Zhang YL, Zhang WX, Yan JQ, Tang YL, Jia WJ, Xu ZW, Xu MJ, Chattipakorn N, Wang Y, Feng JP, Liu ZG, Liang G.
    Acta Pharmacol Sin; 2022 Jan 20; 43(1):76-85. PubMed ID: 34480112
    [Abstract] [Full Text] [Related]

  • 7. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
    Zhang Y, Xu T, Wu B, Chen H, Pan Z, Huang Y, Mei L, Dai Y, Liu X, Shan X, Liang G.
    J Cell Mol Med; 2017 Apr 20; 21(4):746-757. PubMed ID: 27860279
    [Abstract] [Full Text] [Related]

  • 8. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
    Zhang Y, Chen H, Zhang W, Cai Y, Shan P, Wu D, Zhang B, Liu H, Khan ZA, Liang G.
    Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165683. PubMed ID: 31953218
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury.
    Chen H, Zhang Y, Zhang W, Liu H, Sun C, Zhang B, Bai B, Wu D, Xiao Z, Lum H, Zhou J, Chen R, Liang G.
    Phytomedicine; 2019 Oct 01; 63():152997. PubMed ID: 31254764
    [Abstract] [Full Text] [Related]

  • 10. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
    Chen L, Jin Y, Chen H, Sun C, Fu W, Zheng L, Lu M, Chen P, Chen G, Zhang Y, Liu Z, Wang Y, Song Z, Liang G.
    Eur J Med Chem; 2018 Jan 01; 143():361-375. PubMed ID: 29202400
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
    Zhang Y, Liang D, Dong L, Ge X, Xu F, Chen W, Dai Y, Li H, Zou P, Yang S, Liang G.
    Respir Res; 2015 Mar 24; 16(1):43. PubMed ID: 25889862
    [Abstract] [Full Text] [Related]

  • 12. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2.
    Yang L, Luo W, Zhang Q, Hong S, Wang Y, Samorodov AV, Chattipakorn N, Pavlov VN, Liang G.
    Phytomedicine; 2021 Dec 24; 93():153785. PubMed ID: 34638032
    [Abstract] [Full Text] [Related]

  • 13. Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2).
    Zhu W, Wang M, Jin L, Yang B, Bai B, Mutsinze RN, Zuo W, Chattipakorn N, Huh JY, Liang G, Wang Y.
    Br J Pharmacol; 2023 Apr 24; 180(8):1114-1131. PubMed ID: 36480410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI).
    Qian J, Chen X, Shu S, Zhang W, Fang B, Chen X, Zhao Y, Liu Z, Liang G.
    Eur J Med Chem; 2019 Apr 01; 167():414-425. PubMed ID: 30780088
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
    Lee JY, Lee BH, Kim ND, Lee JY.
    J Ethnopharmacol; 2015 Aug 22; 172():254-60. PubMed ID: 26116162
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and optimization of novel allylated mono-carbonyl analogs of curcumin (MACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) in rats.
    Zhu H, Xu T, Qiu C, Wu B, Zhang Y, Chen L, Xia Q, Li C, Zhou B, Liu Z, Liang G.
    Eur J Med Chem; 2016 Oct 04; 121():181-193. PubMed ID: 27240273
    [Abstract] [Full Text] [Related]

  • 20. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
    Chen L, Fu W, Zheng L, Wang Y, Liang G.
    Drug Discov Today; 2018 Jun 04; 23(6):1187-1202. PubMed ID: 29330126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.